Equity Profile

SYK

Stryker Corporation

Health CareHealth Care Equipment$130.8B

Jul30Thu

Pre-Earnings Brief

UpcomingQ2-2026After Close5:00 PM EDT

Company Snapshot

Stryker Corporation (SYK) is a leading medical technology company that develops and manufactures innovative healthcare equipment. Operating in the Health Care sector, Stryker plays a crucial role in improving patient outcomes through its products, which include surgical instruments and orthopedic implants.

Key Metrics to Watch

EPS

Earnings per share is a key indicator of profitability and will show how well the company is managing costs and generating income.

$3.68

Revenue

Total revenue reflects the company's sales performance and demand for its products, which is vital for assessing growth.

$6.7B

Wall Street expectations, options signals, track record, and call prep available with Pro.

SYK Q2-2026 Earnings Preview

Context

Company Snapshot

Earnings Scorecard·Last 8Q

EPS Beat Streak

EPS Beat Rate

88%

Avg EPS Surprise

+0.54%

Avg Stock Reaction

-0.54%

Last Quarter Recap

In Q1-2026, Stryker reported an EPS of $2.60, falling short of the estimate of $2.98, which marked a 12.63% surprise to the downside. The stock remained unchanged the next day, indicating a muted market reaction.

Management Promises & Guidance

Expectations

Wall Street Expectations

Analysts are cautiously optimistic about Stryker's upcoming earnings, with expectations for a rebound in EPS and revenue. However, the recent earnings miss has raised concerns about the company's growth trajectory.

Bull Case

If Stryker can exceed the EPS estimate and show strong revenue growth, it could signal a recovery in demand for its products, leading to a positive market reaction.

Bear Case

Conversely, if the company fails to meet expectations again, it may raise further doubts about its operational efficiency and market demand, potentially leading to a negative stock reaction.

Key Metrics to Watch

EPS

$3.68

Earnings per share is a key indicator of profitability and will show how well the company is managing costs and generating income.

Revenue

$6.7B

Total revenue reflects the company's sales performance and demand for its products, which is vital for assessing growth.

Expectations

Two Questions That Matter

The print will turn on these two things.

Will Stryker's EPS exceed the consensus estimate of $3.68?

A strong EPS result could indicate improved profitability and operational efficiency, which is crucial for investor confidence.

What are the revenue growth trends in key product segments?

Understanding revenue performance in specific areas will help gauge overall demand and market position, influencing future growth expectations.

Edge

What the Street Is Missing

Why consensus could be wrong

The consensus may be underestimating the potential for Stryker to rebound from its recent earnings miss, as the company has historically shown resilience in recovering from setbacks.

Supporting Evidence

Stryker has an 88% EPS beat rate in the last eight quarters, suggesting a strong potential for positive surprises.

The options market is pricing a relatively low move, indicating that traders may not fully anticipate a significant turnaround.

Key Risk

If the company reports strong growth in its key product segments, it could challenge the current bearish sentiment.

Edge

Thesis-Break Levels

Pre-commit to what would confirm each case.

This quarter's performance is critical as it follows a disappointing earnings report, making it essential for Stryker to demonstrate a turnaround.

Bull Confirmed If

Achieving an EPS of $3.75 or higher would confirm strong operational recovery.

Bear Confirmed If

An EPS below $3.00 would signal ongoing challenges in profitability.

Pre-Earnings Positioning

Options Market

Implied Move

±1.09%

Historical Avg

±0.8%

Pricing rich

The options market is pricing in a modest move around the earnings report, suggesting that traders expect some volatility but not a dramatic shift.

Options are pricing ±1.1% while SYK has averaged ±0.8% over the last 8 prints — setup is pricing rich.

Detail

ATM IV

0.3%

30d HV

33.6%

Calls (73K)P/C Ratio: 2.01Puts (54K)

Preparation

Post-Print Playbook

Likely market behavior by outcome — not investment advice.

Beat & Raise

If Stryker beats estimates, history suggests the stock could see a modest positive reaction, confirming a recovery narrative.

In-Line / Cautious

If results are in line with expectations, the stock may experience limited movement as investors await further clarity on growth.

Miss

A miss could lead to a negative reaction, with historical patterns indicating a potential decline in stock value.

Earnings Track Record

Preparation

What to Listen For

Call Prep

1Details on revenue growth in orthopedic and surgical products.
2Any updates on cost management strategies and their impact on margins.
3Insights into market demand trends and competitive positioning.
4Management's outlook on future growth and any new product launches.
5Responses to analyst questions regarding the recent earnings miss.

See the full picture

AI-powered briefs, options data, and 20 quarters of history — everything you need before earnings.

No charge today · Auto-bills $8/mo after 7 days · Cancel anytime

More Earnings This Week

5 Reports

Jul27

KRCAMC

Kilroy Realty Corporation

PreviewView

Jul27

PIIAMC

Company Snapshot

Key Metrics to Watch

EPS

Earnings per share is a key indicator of profitability and will show how well the company is managing costs and generating income.

$3.68

Revenue

Total revenue reflects the company's sales performance and demand for its products, which is vital for assessing growth.

$6.7B

Wall Street expectations, options signals, track record, and call prep available with Pro.

SYK Q2-2026 Earnings Preview

Context

Company Snapshot

Earnings Scorecard·Last 8Q

EPS Beat Streak

EPS Beat Rate

88%

Avg EPS Surprise

+0.54%

Avg Stock Reaction

-0.54%

Last Quarter Recap

Management Promises & Guidance

Expectations

Wall Street Expectations

Bull Case

If Stryker can exceed the EPS estimate and show strong revenue growth, it could signal a recovery in demand for its products, leading to a positive market reaction.

Bear Case

Conversely, if the company fails to meet expectations again, it may raise further doubts about its operational efficiency and market demand, potentially leading to a negative stock reaction.

Key Metrics to Watch

EPS

$3.68

Earnings per share is a key indicator of profitability and will show how well the company is managing costs and generating income.

Revenue

$6.7B

Total revenue reflects the company's sales performance and demand for its products, which is vital for assessing growth.

Expectations

Two Questions That Matter

The print will turn on these two things.

Will Stryker's EPS exceed the consensus estimate of $3.68?

A strong EPS result could indicate improved profitability and operational efficiency, which is crucial for investor confidence.

What are the revenue growth trends in key product segments?

Understanding revenue performance in specific areas will help gauge overall demand and market position, influencing future growth expectations.

Edge

What the Street Is Missing

Why consensus could be wrong

The consensus may be underestimating the potential for Stryker to rebound from its recent earnings miss, as the company has historically shown resilience in recovering from setbacks.

Supporting Evidence

Stryker has an 88% EPS beat rate in the last eight quarters, suggesting a strong potential for positive surprises.

The options market is pricing a relatively low move, indicating that traders may not fully anticipate a significant turnaround.

Key Risk

If the company reports strong growth in its key product segments, it could challenge the current bearish sentiment.

Edge

Thesis-Break Levels

Pre-commit to what would confirm each case.

This quarter's performance is critical as it follows a disappointing earnings report, making it essential for Stryker to demonstrate a turnaround.

Bull Confirmed If

Achieving an EPS of $3.75 or higher would confirm strong operational recovery.

Bear Confirmed If

An EPS below $3.00 would signal ongoing challenges in profitability.

Pre-Earnings Positioning

Options Market

Implied Move

±1.09%

Historical Avg

±0.8%

Pricing rich

The options market is pricing in a modest move around the earnings report, suggesting that traders expect some volatility but not a dramatic shift.

Options are pricing ±1.1% while SYK has averaged ±0.8% over the last 8 prints — setup is pricing rich.

Detail

ATM IV

0.3%

30d HV

33.6%

Calls (73K)P/C Ratio: 2.01Puts (54K)

Preparation

Post-Print Playbook

Likely market behavior by outcome — not investment advice.

Beat & Raise

If Stryker beats estimates, history suggests the stock could see a modest positive reaction, confirming a recovery narrative.

In-Line / Cautious

If results are in line with expectations, the stock may experience limited movement as investors await further clarity on growth.

Miss

A miss could lead to a negative reaction, with historical patterns indicating a potential decline in stock value.

Earnings Track Record

Preparation

What to Listen For

Call Prep

1Details on revenue growth in orthopedic and surgical products.
2Any updates on cost management strategies and their impact on margins.
3Insights into market demand trends and competitive positioning.
4Management's outlook on future growth and any new product launches.
5Responses to analyst questions regarding the recent earnings miss.